Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Borchelt

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 5, 2021
Building a Case for Withaferin A as a Treatment for FTD/ALS SyndromesDavid R Borchelt
The Journal of Clinical Investigation|March 31, 2018
Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid depositionDavid R Borchelt
The New England Journal of Medicine|October 13, 2006
Amyotrophic lateral sclerosis--are microglia killing motor neurons?David R Borchelt
Molecular Neurodegeneration|November 19, 2011
Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded statesMercedes Prudencio, David R Borchelt
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2018
Targeting the Neuromuscular Junction in ALSJames Wymer, David R Borchelt
Cell Reports. Medicine|July 1, 2021
Astrocytic apoE4 and tau: Deadly combination for neuronsParamita Chakrabarty, David R Borchelt
The Journal of Biological Chemistry|March 5, 2008
A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosisCeleste M Karch, David R Borchelt
Journal of Neurochemistry|January 14, 2010
An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosisCeleste M Karch, David R Borchelt
Acta Neuropathologica|September 15, 2020
Phenotypic diversity in ALS and the role of poly-conformational protein misfoldingJacob I Ayers, David R Borchelt
Archives of Biochemistry and Biophysics|August 5, 2010
Aggregation modulating elements in mutant human superoxide dismutase 1Celeste M Karch, David R Borchelt
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 5, 2021
Building a Case for Withaferin A as a Treatment for FTD/ALS SyndromesDavid R Borchelt
The Journal of Clinical Investigation|March 31, 2018
Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid depositionDavid R Borchelt
The New England Journal of Medicine|October 13, 2006
Amyotrophic lateral sclerosis--are microglia killing motor neurons?David R Borchelt
Molecular Neurodegeneration|November 19, 2011
Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded statesMercedes Prudencio, David R Borchelt
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2018
Targeting the Neuromuscular Junction in ALSJames Wymer, David R Borchelt
Cell Reports. Medicine|July 1, 2021
Astrocytic apoE4 and tau: Deadly combination for neuronsParamita Chakrabarty, David R Borchelt
The Journal of Biological Chemistry|March 5, 2008
A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosisCeleste M Karch, David R Borchelt
Journal of Neurochemistry|January 14, 2010
An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosisCeleste M Karch, David R Borchelt
Acta Neuropathologica|September 15, 2020
Phenotypic diversity in ALS and the role of poly-conformational protein misfoldingJacob I Ayers, David R Borchelt
Archives of Biochemistry and Biophysics|August 5, 2010
Aggregation modulating elements in mutant human superoxide dismutase 1Celeste M Karch, David R Borchelt
Pageof 16